University Of Guadalajara
Clinical trials sponsored by University Of Guadalajara, explained in plain language.
-
Could nopal, cacao, and cricket help fatty liver?
Disease control ENROLLING_BY_INVITATIONThis study tests a supplement made from nopal, cacao, and cricket in 60 adults with fatty liver disease (MASLD). Participants take the supplement or a placebo daily for 3 months, along with dietary guidance. The goal is to see if the supplement reduces liver fat, improves health …
Phase: NA • Sponsor: University of Guadalajara • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a common diabetes drug help transplanted kidneys survive longer?
Disease control OngoingThis study tests whether dapagliflozin, a drug usually used for diabetes, can improve kidney function in people who have received a kidney from a living donor. Fifty-four adult transplant recipients will take either dapagliflozin or standard care for 12 months. Researchers will m…
Phase: PHASE2 • Sponsor: University of Guadalajara • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study aims to find best CMV prevention for kidney transplant patients
Disease control OngoingThis study looks at two different approaches to prevent cytomegalovirus (CMV) infection in people who have received a kidney transplant from a living donor. The participants are at intermediate risk for CMV and are given standard anti-rejection medication. The goal is to see whic…
Phase: PHASE4 • Sponsor: University of Guadalajara • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Probiotics vs. metformin: a new hope for prediabetes?
Disease control OngoingThis study tests whether probiotics can control blood sugar as well as metformin in people with prediabetes. Thirty adults aged 31-60 with prediabetes will take either probiotics or metformin for 13 weeks. The goal is to see if probiotics offer a new treatment option to prevent t…
Phase: PHASE2 • Sponsor: University of Guadalajara • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC